Testing Requirements for Living Kidney Donors Post-Travel to Guatemala and Belize
Standard Infectious Disease Screening
- The American College of Surgeons recommends that all living kidney donors require baseline infectious disease screening regardless of travel history, including HIV, HBV, HCV testing, which must be current within 28 days of donation 1, 2
- The American Society of Transplantation suggests that CMV and EBV serologies should be included in the baseline screening 1
- The Centers for Disease Control and Prevention recommends syphilis testing (RPR) as part of the baseline screening 1, 2
- The National Kidney Foundation advises that urinalysis to detect asymptomatic urinary tract infections should be included in the baseline screening 1, 2
Additional Testing for Central American Travel
- The American Society of Tropical Medicine and Hygiene recommends parasitic infection testing (stool examination for ova and parasites) for donors with recent travel to Guatemala and Belize 1
- The World Health Organization suggests consideration for malaria testing, especially if visiting rural areas 1
- The Centers for Disease Control and Prevention recommends arbovirus testing if symptomatic (dengue, chikungunya, Zika) 1
Timing Considerations
- The American College of Surgeons recommends that testing should be performed 2-4 weeks after return from travel to allow adequate time for potential infections to become detectable 1
- The National Kidney Foundation advises that all infectious disease testing must be completed within 28 days of the planned donation surgery 1
- The Clinical Microbiology and Infection society notes that this timing window is critical to avoid false-negative results during the "window period" of infections 3, 4
Risk Assessment Framework
- The American Society of Transplantation recommends that the transplant team must carefully evaluate any positive findings to determine donor eligibility 1
- The Clinical Microbiology and Infection society suggests that viraemic donors should be rejected, particularly for infections like West Nile Virus if traveling during an outbreak period 3, 4
- The National Kidney Foundation advises that donor-derived infections can have significant morbidity and mortality implications for immunosuppressed recipients 3, 4
Documentation Requirements
- The American College of Surgeons recommends that complete travel history must be documented, including specific regions visited within Guatemala and Belize, dates of travel and return, all screening tests performed and results, and risk assessment findings 1
Common Pitfalls to Avoid
- The American Society of Transplantation notes that inadequate timing of testing may miss infections in the incubation period 1
- The Clinical Microbiology and Infection society warns that overlooking the window period for viral infections can lead to undetected transmissible diseases 3, 4
- The National Kidney Foundation advises that failing to consult with infectious disease specialists when evaluating donors with travel to endemic regions can lead to inadequate risk assessment 1
- The World Health Organization recommends considering geographically restricted infectious agents that may be endemic to Central America 3, 4
Additional Considerations
- The American Journal of Transplantation suggests that if the donor is related to the recipient, genetic testing may be necessary if there is a family history of kidney disease 5, 6, 7
- The American Society of Transplantation recommends that standard pre-donation workup should still be completed, including kidney function assessment, cardiovascular evaluation, and metabolic screening 2
Infectious Disease Testing Requirements for Potential Kidney Donors After Travel
Standard Testing Timeline Requirements
- The Clinical Microbiology and Infection society emphasizes that a minimum of 4 weeks (28 days) after return from travel is required to allow adequate detection of potential infections, as the timing window is critical to avoid false-negative results during the "window period" of infections 8
- False-negative test results can occur with HIV and HCV antibody testing during window periods, which can be reduced but not eliminated with nucleic acid testing (NAT), according to the Clinical Microbiology and Infection society 9
Required Testing for All Potential Kidney Donors
- NAT testing can reduce but not eliminate the window period from infection to viral detection (5-10 days for HIV, 3-5 days for HCV, and 20-22 days for HBV), as stated by the Clinical Microbiology and Infection society 9
- Blood cultures should be collected if the donor has been hospitalized for more than 48-72 hours, as recommended by the Clinical Microbiology and Infection society 8
Additional Testing Based on Travel History
- Donors who have traveled to endemic areas require additional screening for geographically restricted infectious agents, according to the Clinical Microbiology and Infection society 10
- Testing for endemic fungal infections may be necessary depending on the region visited, as stated by the Clinical Microbiology and Infection society 10
Risks of Inadequate Testing
- Transmission of tickborne rickettsial infections through solid organ transplantation has been documented, and donors who are asymptomatic or in the presymptomatic period pose the greatest risk of disease transmission, as reported by the MMWR Recommendations and Reports 11
- Transfusion-associated transmission is of special concern for immunosuppressed recipients who are at greater risk for severe or fatal outcomes, according to the MMWR Recommendations and Reports 11